dndn is scheduled to release its interim data before April, I think now stock market has very low appetite for risk, best time for risky investment, it is a binary event for biotech, as always. But at 2.9 level, there is not much down side any more, plenty of upside.

DNDN can be a small revolution just like DNA, a new tech against cancer. From its working theory, it can be used against multiple cancer just like DNA\'s tech.

By the way, a new FDA head is coming.

a good intro for DNDN:

http://boards.fool.com/Message.asp?mid=27312487

a detailed analysis for coming event:

http://www.fool.com/investing/high-growth/2008/03/17/parsing-the-details-with-dendreon.aspx

another one:

http://www.minyanville.com/articles/PFE-BMY-NBIX-WYE-ZGEN-rprx/index/a/20780/p/2
Finger crossed.